The mission of BioCrossroads is to serve as a catalyst for the continued growth of Indiana’s robust life sciences industry.

NEWSFEED

IU School of Medicine research leads to new drug for rare bone disease

Research led by two Indiana University School of Medicine faculty members has culminated in U.S. Food and Drug Administration approval of a new drug for patients with an uncommon, painful and...

New minimally invasive, cost-effective method shows promise in treating cancer without harming healthy cells

A Purdue innovation, called PLASMAT, combines three emerging techniques that appear promising in the fight against most types of cancer. WEST LAFAYETTE, Ind. – Purdue University researchers have...

New minimally invasive, cost-effective method shows promise in treating cancer without harming healthy cells

A Purdue innovation, called PLASMAT, combines three emerging techniques that appear promising in the fight against most types of cancer. WEST LAFAYETTE, Ind. – Purdue University researchers have...

New minimally invasive, cost-effective method shows promise in treating cancer without harming healthy cells

A Purdue innovation, called PLASMAT, combines three emerging techniques that appear promising in the fight against most types of cancer. WEST LAFAYETTE, Ind. – Purdue University researchers have...

Scioto Biosciences Closes $1.8M in Series A Financing, Receives NIH and State of Indiana Grants Funding to Support Launch of New Microbiome Platform Technology

Indianapolis, IN (May 21, 2018) – Scioto Biosciences, a preclinical stage company developing innovative therapies to transform the delivery of microbiome therapeutics, today announced it has closed...

Scioto Biosciences Closes $1.8M in Series A Financing, Receives NIH and State of Indiana Grants Funding to Support Launch of New Microbiome Platform Technology

FAST BioMedical’s Phase 2 Clinical Trial Results Published in the Prestigious Journal of the American Society of Nephrology

Carmel, IN — May 18, 2018 — FAST BioMedical announced today the recent publication of their Phase 2 clinical trial data on kidney function measurement in the Journal of the American Society of...

FAST BioMedical’s Phase 2 Clinical Trial Results Published in the Prestigious Journal of the American Society of Nephrology

Carmel, IN — May 18, 2018 — FAST BioMedical announced today the recent publication of their Phase 2 clinical trial data on kidney function measurement in the Journal of the American Society of...

SUBMIT YOUR OWN LIFE SCIENCES NEWS STORY

SUBMIT STORY

ADVANCING A CATALYTIC STATE

We implement our mission by connecting with corporate, academic and philanthropic partners; facilitating investments in promising start ups and building new enterprises; and educating through conferences, reports and market development knowledge.